Hawaiian Baby Woodrose - Faslodex (Fulvestrant) Interaction
Herbal: Hawaiian Baby Woodrose
Also Known As: Argyreia nervosa, Baby Hawaiian Woodrose, Baby Woodrose, Bidhara, Elephant Climber, Elephant Creeper, Liane d'Argent, Rose des Bois, Silver-Morning-Glory, Vidhara, Vriddadaru, Vridhadaru, Wood-Rose, Woolly Morning Glory
Drug: Fulvestrant
Brand names:
Faslodex
Medical Content Editor Dr. Brian Staiger, PharmD
Last updated
Jun 22, 2025
Interaction Details
There were no interactions found between Fulvestrant and Hawaiian Baby Woodrose. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Hawaiian Baby Woodrose Overview
Hawaiian baby woodrose (Argyreia nervosa) is a flowering plant native to tropical areas of India, Nepal, and the Philippines. It is a member of the Convolvulaceae family and related to the common flower morning glory. Hawaiian baby woodrose is known for its large, heart-shaped leaves and purple flowers. The seeds of the plant contain lysergic acid amide, which is similar in structure to LSD. It has been used in traditional medicine for its purported analgesic, and hallucinogenic effects. Due to the potential safety concerns with the medicinal use Hawaiian baby woodrose, its use is generally not recommended.
Fulvestrant Overview
-
Fulvestrant injection is used alone or in combination with ribociclib (Kisqali®) to treat a certain type of hormone receptor positive, advanced breast cancer (breast cancer that depends on hormones such as estrogen to grow) or breast cancer has spread to other parts of the body in women who have experienced menopause (change of life; end of monthly menstrual periods) and have not previously been treated with an anti-estrogen medication such as tamoxifen (Nolvadex). Fulvestrant injection is also used alone or in combination with ribociclib (Kisqali®) to treat hormone receptor positive, advanced breast cancer or breast cancer that has spread to other parts of the body in women who have experienced menopause and whose breast cancer has worsened after they were treated with an anti-estrogen medication such as tamoxifen. Fulvestrant injection is also used in combination with palbociclib (Ibrance®) or abemaciclib (Verzenio®) to treat hormone receptor positive, advanced breast cancer in women whose breast cancer has spread to other parts of the body and has worsened after they were treated with anti-estrogen medication such as tamoxifen. Fulvestrant is in a class of medications called estrogen receptor antagonists. It works by blocking the action of estrogen on cancer cells. This can slow or stop the growth of some breast tumors that need estrogen to grow.
Hawaiian Baby Woodrose - More Interactions
Hawaiian Baby Woodrose interacts with 181 drugs
Interaction Rating Key
These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.
| Major | The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur. |
| Moderate | Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur. |
| Minor | Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction. |
| Unknown | No interactions have been reported or no interaction data is currently available. |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.
Ask A Pharmacist About Your Herbal Questions!
Dr. Brian Staiger, PharmD
In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. He has combined his passion for pharmacy practice with the study of medical ethnobotany to improve patient care. Feel free to reach out about any of your herbal or medication questions!
Ask A Pharmacist